Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study.

scientific article

Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000188848
P698PubMed publication ID8684533

P2093author name stringT Kokubo
Y Kobayashi
A Horii
Y Hiki
S Tateno
P433issue2
P304page(s)237-242
P577publication date1996-01-01
P1433published inThe Nephron JournalsQ15745443
P1476titleSteroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study.
P478volume72

Reverse relations

cites work (P2860)
Q33932591A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy
Q35894999A treatment dilemma in adult immunoglobulin A nephropathy: what is the appropriate target, preservation of kidney function or induction of clinical remission?
Q87393387Chapter 10: Immunoglobulin A nephropathy
Q46744590Clinical assessment of low-dose steroid therapy for patients with IgA nephropathy: a prospective study in a single center
Q28361134Clinical course of patients with IgA nephropathy between combined treatment of immunosuppressive agents and ACE inhibitor and ACE inhibitor alone
Q36234400Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine
Q50230374Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients with IgA nephropathy
Q84196917Complete remission within 2 years predicts a good prognosis after methylprednisolone pulse therapy in patients with IgA nephropathy
Q37108501Continental variations in IgA nephropathy among Asians
Q44423474Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy
Q44419929Corticosteroids in IgA nephropathy: a randomised controlled trial
Q58761828Corticosteroids pulse therapy and oral corticosteroids therapy for IgA nephropathy patients with advanced chronic kidney disease: results of a multicenter, large-scale, long-term observational cohort study
Q73453299Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy
Q35995685Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients.
Q84978295Evidence-based practice guideline for the treatment of CKD
Q46846514Histologically advanced IgA nephropathy treated successfully with prednisolone and cyclophosphamide
Q36577108IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors
Q55509866Immunosuppressive Treatment in Children With IgA Nephropathy and the Clinical Value of Podocytopathic Features.
Q24188035Immunosuppressive agents for treating IgA nephropathy
Q24247680Immunosuppressive agents for treating IgA nephropathy
Q90254423Immunosuppressive agents for treating IgA nephropathy
Q46715751Long-term follow-up of patients with IgA nephropathy treated with prednisolone and cyclophosphamide therapy
Q51680137Mechanism of onset and exacerbation of chronic glomerulonephritis and its treatment.
Q51595672New treatment for IgA nephropathy: enteric budesonide targeted to the ileocecal region ameliorates proteinuria.
Q35128270Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan
Q33863555Rationales for treating IgA nephropathies
Q57945954References
Q86715995Renal outcome after tonsillectomy plus corticosteroid pulse therapy in patients with immunoglobulin A nephropathy: results of a multicenter cohort study
Q43703528Role of proteinuria reduction in the progression of IgA nephropathy
Q33886910Steroids in the treatment of IgA nephropathy to the improvement of renal survival: a systematic review and meta-analysis
Q27005109The Treatment of IgA Nephropathy
Q37090470The improvement of renal survival with steroid pulse therapy in IgA nephropathy
Q37115267The predictive value of attenuated proteinuria at 1 year after steroid therapy for renal survival in patients with IgA nephropathy
Q35852475Therapeutic approach of patients with IgA nephropathy
Q38689787Treatment of IgA nephropathy with renal insufficiency
Q38860793Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?

Search more.